GRAS Notices
-
GRN No. 1002
Bifidobacterium breve strain MCC1274
Intended Use: | Intended for use as an ingredient in conventional foods including baked goods, breakfast cereals, fruit juices and nectars, fruit ices, vegetable juices, milk-based drinks and powders, yogurt, dairy product analogs, frozen dairy desserts, cheeses, condiments and spreads, nut and peanut spreads, gelatins and puddings, milk and non-milk meal replacements, and soft and hard candies and snack foods at a maximum level of 5 x 1010 colony forming units (CFU)/serving. |
---|---|
Basis: | Scientific procedures |
Notifier: | Morinaga Milk Industry Co., Ltd. |
Notifier Address: |
33-1, Shiba 5-Chome, Minato-ku Tokyo 108-8384 JAPAN |
GRAS Notice (releasable information): | GRN 1002 with amendments (in PDF) (3.6 MB) |
Date of closure: | Jul 22, 2022 |
FDA's Letter: | FDA has no questions (in PDF) (221 kB) |
-